Clinical trials
Terminated Phase 1 Gliosarcoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2005 | 2 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 3 |
| 2010 | 3 |
| 2011 | 2 |
| 2012 | 2 |
| 2014 | 2 |
| 2017 | 1 |
| 2018 | 2 |
| 2021 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 25 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 7 |
| M.D. Anderson Cancer Center | 4 |
| Case Comprehensive Cancer Center | 2 |
| Abramson Cancer Center at Penn Medicine | 1 |
| Barbara Ann Karmanos Cancer Institute | 1 |
| Cancer Research UK | 1 |
| Daniel Landi | 1 |
| Emory University | 1 |
| Gary Archer Ph.D. | 1 |
| Northwestern University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glioblastoma | 25 |
| Gliosarcoma | 25 |
| Brain Neoplasms | 11 |
| Oligodendroglioma | 11 |
| Astrocytoma | 10 |
| Glioma | 9 |
| Central Nervous System Neoplasms | 5 |
| Ependymoma | 3 |
| Glioma, Subependymal | 2 |
| Neuroectodermal Tumors, Primitive | 2 |
Trials
Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.